Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma Roche, 28 Mar 2014 Accessed on 1 Apr 2014 from http://www.roche.com/media/media_releases/med-cor-2014-03-28.htm. CommentRecommendBookmarkWatch